Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | FLT3 | P36888 | 5/20 | 0.34 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | KIT | P10721 | 1/20 | 0.34 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.32 |
| ▸ | CCNK | O75909 | 1/20 | 0.32 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.32 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.30 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3973855 | 0.86 | GRIN2D (0.34) | HSP90AA1NUDT1HRH4CCNKCDK12 | |
| SCHEMBL3978017 | 0.81 | HSP90AA1 (0.34) | HSP90AA1 | |
| SCHEMBL1343551 | 0.81 | PDK1 (0.35) | HSP90AA1PDK1PDK2PDK3PDK4 | |
| SCHEMBL3972571 | 0.81 | HSP90AA1 (0.34) | HSP90AA1 | |
| SCHEMBL1147866 | 0.77 | HSD11B1 (0.32) | HSP90AA1 | |
| SCHEMBL1147785 | 0.77 | PIK3CD (0.36) | HSP90AA1 | |
| SCHEMBL3971042 | 0.76 | HSP90AA1 (0.32) | HSP90AA1 | |
| SCHEMBL930756 | 0.75 | ESR1 (0.39) | HSP90AA1 | |
| SCHEMBL1148407 | 0.75 | GAA (0.36) | HSP90AA1 | |
| SCHEMBL1502369 | 0.74 | FLT3 (0.37) | HSP90AA1FLT3PDGFRBKITNUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008051416-A2 | COMPOUNDS THAT INHIBIT THE ACTIVITY OF HSP90 FOR TREATING INFECTIONS | SYNTA PHARMACEUTICALS CORP. (US) | 2008-05-02 | — | — | WO | disclosed |